Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDPHV With Either Alhydrogel or GLA-SE in Healthy Adults Living Without HIV
NCT07675629Phase 2Not yet recruiting
- Sponsor
- Worcester HIV Vaccine
- Start
- Sep 2026
- Primary completion
- Aug 2028
- Countries
- 2
01
Overview
A Phase 2 trial of PDPHV Plasmid DNA Vaccines in human immunodeficiency virus infection (HIV), sponsored by Worcester HIV Vaccine. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
PDPHV Plasmid DNA Vaccines
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07675629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07675629.